カルシトニン注射液の世界市場レポート 2025年

カルシトニン注射液市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で9億9,000万米ドルに成長します。予測期間における成長は、骨関連治療に対する需要の増加、バイオシミラー競合の出現、新興市場における需要の高まり、個別化医療へのシフト、カルシトニンの代替用途に関する研究の拡大に起因すると考えられます。この期間に予想される主要動向には、経鼻と注射投与システムの発展、半減期延長製剤の開発、バイオシミラーカルシトニン製剤の導入、骨粗鬆症治療アプローチの革新、診断技術の改善などがあります。

骨粗鬆症の有病率の上昇は、今後数年間のカルシトニン注射液市場の成長を牽引すると予想されます。骨粗鬆症は、骨密度の低下と骨折のしやすさが特徴的な病態であり、主に高齢者、特に閉経後の女性が罹患します。この有病率の増加は、平均寿命の延長が自然な骨量減少と骨粗鬆症リスクの上昇に寄与しているため、世界人口の高齢化が主要原因となっています。カルシトニン注射剤は、カルシウム濃度を調節し、骨の分解を遅らせることによって骨密度を維持し、骨粗鬆症の管理に重要な役割を果たしています。また、投与が容易であるため、患者の服薬アドヒアランスが向上し、骨折のリスクも低減します。例えば、2024年6月、オーストラリア保健福祉ラボは、2022年に85万3,600人（人口の3.4％）が骨粗鬆症または骨減少症に罹患し、2,659人（記録された全死亡の1.4％）が死亡したと報告しました。このように、骨粗鬆症の負担増がカルシトニン注射剤の需要を促進しています。

カルシトニン注射液市場の主要企業は、治療効果と患者の転帰を改善するため、USP合成注射剤のような革新的製品の開発を重視しています。USP合成注射剤は、米国薬局方（USP）が定める厳格な品質、純度、強度、同一性基準に準拠した合成活性成分で製剤化されています。これらの製品は、安全性と治療効果を確保するため、厳しい条件下で製造されています。例えば、2025年2月、ドイツに本社を置く製薬会社フレゼニウス・カビは、症候性骨ページェット病と高カルシウム血症治療用のUSP合成カルシトニンサルモン注射液を発売しました。この無菌溶液は筋肉内または皮下投与用に設計されており、1mLあたり200USP単位の濃度で提供され、2mLマルチドーズバイアル（400USP単位）に包装されています。注射液は2℃～8℃の冷蔵保存が必要です。カルシウム調整剤として作用し、高カルシウム血症や閉経後骨粗鬆症など、代替療法が適さない場合に適応となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のカルシトニン注射液：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のカルシトニン注射液市場：成長率分析
• 世界のカルシトニン注射液市場の実績：規模と成長、2019～2024年
• 世界のカルシトニン注射液市場の予測：規模と成長、2024～2029年、2034年
• 世界のカルシトニン注射液：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のカルシトニン注射液市場：カルシトニンタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• サケカルシトニン
• ヒトカルシトニン
• 合成カルシトニン
• 世界のカルシトニン注射液市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 静脈内（IV）注射
• 皮下注射
• 筋肉内注射
• 世界のカルシトニン注射液市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 直接販売
• オンライン薬局
• 小売薬局
• ヘルスケア機関
• 世界のカルシトニン注射液市場：治療用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 骨粗鬆症の治療
• パジェット病の管理
• 高カルシウム血症のコントロール
• 骨転移治療
• 世界のカルシトニン注射液市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 専門クリニック
• 高齢者介護施設
• 在宅ヘルスケア
• 世界のカルシトニン注射液市場、サケカルシトニンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 合成サーモンカルシトニン
• 組換えサーモンカルシトニン
• 世界のカルシトニン注射液市場、ヒトカルシトニンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 組換えヒトカルシトニン
• 合成ヒトカルシトニン
• 世界のカルシトニン注射液市場、合成カルシトニンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ペプチドベースの合成カルシトニン
• アナログ合成カルシトニン

第7章 地域別・国別分析

• 世界のカルシトニン注射液市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のカルシトニン注射液市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• カルシトニン注射液市場：競合情勢
• カルシトニン注射液市場：企業プロファイル
  • Kaiser Permanente
  • F. Hoffmann-La Roche AG
  • Sanofi S.A.
  • Novartis AG
  • AstraZeneca plc

第31章 その他の大手企業と革新的企業

• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Fresenius Kabi AG
• Sun Pharmaceutical Industries Limited
• Dr. Reddy's Laboratories Limited
• Cipla Limited
• Hikma Pharmaceuticals plc
• Endo International plc
• Asahi Kasei Pharma Corporation
• Torrent Pharmaceuticals Limited
• BCN Peptides S.L.
• SG Pharmaceuticals Pvt Ltd
• Leucadia Pharmaceuticals Inc.
• Polypeptide Group AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• カルシトニン注射液市場、2029年：新たな機会を提供する国
• カルシトニン注射液市場、2029年：新たな機会を提供するセグメント
• カルシトニン注射液市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Calcitonin injection is a medication used to treat a range of bone-related conditions by inhibiting bone resorption and increasing calcium excretion through the kidneys. It is commonly administered via subcutaneous or intramuscular injection and is often derived from salmon, which exhibits a similar but more potent effect compared to human calcitonin.

The main types of calcitonin injection include salmon calcitonin, human calcitonin, and synthetic calcitonin. Salmon calcitonin refers to a form of the hormone either synthesized or derived from salmon, known for its higher potency. These injections can be administered through various routes, such as intravenous (IV), subcutaneous, or intramuscular methods. Distribution channels for these medications include direct sales, online pharmacies, retail pharmacies, and healthcare institutions. Calcitonin injections fall under several drug classes, including treatments for osteoporosis, Paget's disease, hypercalcemia, and bone metastases. They are utilized by various end users, such as hospitals, specialty clinics, geriatric care facilities, and home healthcare providers.

The calcitonin injection market research report is one of a series of new reports from The Business Research Company that provides calcitonin injection market statistics, including calcitonin injection industry global market size, regional shares, competitors with a calcitonin injection market share, calcitonin injection market segments, market trends and opportunities, and any further data you may need to thrive in the calcitonin injection industry. This calcitonin injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The calcitonin injection market size has grown strongly in recent years. It will grow from $0.67 billion in 2024 to $0.73 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. Growth during the historic period can be attributed to the rising prevalence of osteoporosis, increased awareness of bone health, expansion of treatment options for postmenopausal women, the availability of government healthcare subsidies, and a growing geriatric population.

The calcitonin injection market size is expected to see strong growth in the next few years. It will grow to $0.99 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. Growth in the forecast period can be attributed to increasing demand for bone-related treatments, the emergence of biosimilar competition, rising demand in emerging markets, a shift toward personalized medicine, and expanding research into alternative applications of calcitonin. Key trends expected during this period include advancements in intranasal and injectable delivery systems, the development of extended half-life formulations, the introduction of biosimilar calcitonin products, innovation in osteoporosis treatment approaches, and improvements in diagnostic technologies.

The rising prevalence of osteoporosis is expected to drive the growth of the calcitonin injection market in the coming years. Osteoporosis is a condition marked by reduced bone density and increased susceptibility to fractures, primarily affecting older adults, particularly postmenopausal women. This growing prevalence is largely attributed to the aging global population, as extended life expectancy contributes to natural bone loss and a heightened risk of osteoporosis. Calcitonin injections play a key role in managing the condition by regulating calcium levels and slowing bone degradation, thereby helping to preserve bone density. Their ease of administration also enhances patient adherence and reduces the risk of fractures. For example, in June 2024, the Australian Institute of Health and Welfare reported that 853,600 people (3.4% of the population) were living with osteoporosis or osteopenia in 2022, accounting for 2,659 deaths, or 1.4% of all recorded deaths. Thus, the growing burden of osteoporosis is fueling demand for calcitonin injections.

Leading companies in the calcitonin injection market are emphasizing the development of innovative products such as USP synthetic injections to improve treatment efficacy and patient outcomes. USP synthetic injections are formulated with synthetically produced active ingredients that comply with the rigorous quality, purity, strength, and identity standards set by the United States Pharmacopeia (USP). These products are manufactured under stringent conditions to ensure safety and therapeutic effectiveness. For example, in February 2025, Fresenius Kabi, a Germany-based pharmaceutical company, launched a USP synthetic calcitonin salmon injection for the treatment of symptomatic Paget's disease of bone and hypercalcemia. This sterile solution is designed for intramuscular or subcutaneous use, provided at a concentration of 200 USP units per mL and packaged in a 2 mL multi-dose vial (400 USP units). The injection must be refrigerated between 2°C and 8°C. Acting as a calcium regulator, it is indicated for cases where alternative therapies are unsuitable, including hypercalcemia and postmenopausal osteoporosis.

In April 2022, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, acquired Custopharm Inc. for an undisclosed sum. This acquisition was intended to bolster Hikma's U.S. injectables division by broadening its product range, advancing its research and development capabilities, and accelerating growth in the generic sterile injectable market. Custopharm Inc., based in the U.S., develops calcitonin salmon injection marketed under the brand name Calcimar.

Major players in the calcitonin injection market are Kaiser Permanente, F. Hoffmann-La Roche AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Torrent Pharmaceuticals Limited, BCN Peptides S.L., SG Pharmaceuticals Pvt Ltd, Leucadia Pharmaceuticals Inc., Polypeptide Group AB.

North America was the largest region in the calcitonin injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in calcitonin injection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the calcitonin injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The calcitonin injection market consists of sales of combination therapy packs, single-dose and multi-dose vials, branded formulations and generic versions of calcitonin products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Calcitonin Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on calcitonin injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for calcitonin injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The calcitonin injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Calcitonin: Salmon Calcitonin; Human Calcitonin; Synthetic Calcitonin
• 2) By Route Of Administration: Intravenous (IV) Injection; Subcutaneous Injection; Intramuscular Injection
• 3) By Distribution Channel: Direct Sales; Online Pharmacy; Retail Pharmacy; Healthcare Institutions
• 4) By Therapeutic Application: Osteoporosis Treatment; Pagets Disease Management; Hypercalcemia Control; Bone Metastases Therapy
• 5) By End-User: Hospitals; Specialty Clinics; Geriatric Care Facilities; Home Healthcare
• Subsegments:

1) By Salmon Calcitonin; Synthetic Salmon Calcitonin; Recombinant Salmon Calcitonin

2) By Human Calcitonin; Recombinant Human Calcitonin; Synthetic Human Calcitonin

3) By Synthetic Calcitonin; Peptide-Based Synthetic Calcitonin; Analog Synthetic Calcitonin

• Companies Mentioned: Kaiser Permanente; F. Hoffmann-La Roche AG; Sanofi S.A.; Novartis AG; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Calcitonin Injection Market Characteristics

3. Calcitonin Injection Market Trends And Strategies

4. Calcitonin Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Calcitonin Injection Growth Analysis And Strategic Analysis Framework

• 5.1. Global Calcitonin Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Calcitonin Injection Market Growth Rate Analysis
• 5.4. Global Calcitonin Injection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Calcitonin Injection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Calcitonin Injection Total Addressable Market (TAM)

6. Calcitonin Injection Market Segmentation

• 6.1. Global Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Salmon Calcitonin
• Human Calcitonin
• Synthetic Calcitonin
• 6.2. Global Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV) Injection
• Subcutaneous Injection
• Intramuscular Injection
• 6.3. Global Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Online Pharmacy
• Retail Pharmacy
• Healthcare Institutions
• 6.4. Global Calcitonin Injection Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osteoporosis Treatment
• Pagets Disease Management
• Hypercalcemia Control
• Bone Metastases Therapy
• 6.5. Global Calcitonin Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Geriatric Care Facilities
• Home Healthcare
• 6.6. Global Calcitonin Injection Market, Sub-Segmentation Of Salmon Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Salmon Calcitonin
• Recombinant Salmon Calcitonin
• 6.7. Global Calcitonin Injection Market, Sub-Segmentation Of Human Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Human Calcitonin
• Synthetic Human Calcitonin
• 6.8. Global Calcitonin Injection Market, Sub-Segmentation Of Synthetic Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peptide-Based Synthetic Calcitonin
• Analog Synthetic Calcitonin

7. Calcitonin Injection Market Regional And Country Analysis

• 7.1. Global Calcitonin Injection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Calcitonin Injection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Calcitonin Injection Market

• 8.1. Asia-Pacific Calcitonin Injection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Calcitonin Injection Market

• 9.1. China Calcitonin Injection Market Overview
• 9.2. China Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Calcitonin Injection Market

• 10.1. India Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Calcitonin Injection Market

• 11.1. Japan Calcitonin Injection Market Overview
• 11.2. Japan Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Calcitonin Injection Market

• 12.1. Australia Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Calcitonin Injection Market

• 13.1. Indonesia Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Calcitonin Injection Market

• 14.1. South Korea Calcitonin Injection Market Overview
• 14.2. South Korea Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Calcitonin Injection Market

• 15.1. Western Europe Calcitonin Injection Market Overview
• 15.2. Western Europe Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Calcitonin Injection Market

• 16.1. UK Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Calcitonin Injection Market

• 17.1. Germany Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Calcitonin Injection Market

• 18.1. France Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Calcitonin Injection Market

• 19.1. Italy Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Calcitonin Injection Market

• 20.1. Spain Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Calcitonin Injection Market

• 21.1. Eastern Europe Calcitonin Injection Market Overview
• 21.2. Eastern Europe Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Calcitonin Injection Market

• 22.1. Russia Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Calcitonin Injection Market

• 23.1. North America Calcitonin Injection Market Overview
• 23.2. North America Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Calcitonin Injection Market

• 24.1. USA Calcitonin Injection Market Overview
• 24.2. USA Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Calcitonin Injection Market

• 25.1. Canada Calcitonin Injection Market Overview
• 25.2. Canada Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Calcitonin Injection Market

• 26.1. South America Calcitonin Injection Market Overview
• 26.2. South America Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Calcitonin Injection Market

• 27.1. Brazil Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Calcitonin Injection Market

• 28.1. Middle East Calcitonin Injection Market Overview
• 28.2. Middle East Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Calcitonin Injection Market

• 29.1. Africa Calcitonin Injection Market Overview
• 29.2. Africa Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Calcitonin Injection Market Competitive Landscape And Company Profiles

• 30.1. Calcitonin Injection Market Competitive Landscape
• 30.2. Calcitonin Injection Market Company Profiles
  • 30.2.1. Kaiser Permanente Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Calcitonin Injection Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Viatris Inc.
• 31.4. Fresenius Kabi AG
• 31.5. Sun Pharmaceutical Industries Limited
• 31.6. Dr. Reddy's Laboratories Limited
• 31.7. Cipla Limited
• 31.8. Hikma Pharmaceuticals plc
• 31.9. Endo International plc
• 31.10. Asahi Kasei Pharma Corporation
• 31.11. Torrent Pharmaceuticals Limited
• 31.12. BCN Peptides S.L.
• 31.13. SG Pharmaceuticals Pvt Ltd
• 31.14. Leucadia Pharmaceuticals Inc.
• 31.15. Polypeptide Group AB

32. Global Calcitonin Injection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Calcitonin Injection Market

34. Recent Developments In The Calcitonin Injection Market

35. Calcitonin Injection Market High Potential Countries, Segments and Strategies

• 35.1 Calcitonin Injection Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Calcitonin Injection Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Calcitonin Injection Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer